Join
Live feed
·
INSIDERFilingvia Quantisnow
Acer Therapeutics Inc. logo

Dunn John Michael returned 27,380 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ACER· Acer Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ACER (Acer Therapeutics Inc.) and more on Quantisnow.